Preoperative Neutrophil-to-Lymphocyte Ratio Plus Platelet-to-Lymphocyte Ratio Predicts the Outcomes after Curative Resection for Hepatocellular Carcinoma
International Journal of Hepatology · 02.04.2019 · 2019 · 1-9
DOI: 10.1155/2019/4239463 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Hepatology, erschienen am 02.04.2019. Verfasst von T Kabir und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Tan Tock Seng Hospital, Singapore. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In recent years, inflammation-based scoring systems have been reported to predict survival in Hepatocellular Carcinoma (HCC). The aim of our study was to validate combined preoperative Neutrophil-to-Lymphocyte ratio (NLR)-Platelet-to-Lymphocyte ratio (PLR) in predicting overall survival (OS) and recurrence free survival (RFS) in patients who underwent curative resection for HCC.
Methods
We conducted a retrospective study of HCC patients underwent liver resection with curative intent from January 2010 to December 2013. Receiver-operating characteristic (ROC) curve analysis was used to determine the optimal cut-off values for NLR and PLR. Patients with both NLR and PLR elevated were allocated a score of 2; patients showing one or neither of these indices elevated were accorded a score of 1 or 0, respectively.
Results
132 patients with a median age of 66 years (range 18-87) underwent curative resection for HCC. Overall morbidity was 30.3%, 30-day mortality was 2.3%, and 90-day mortality was 6.8%. At a median follow-up of 24 months (range 1-88), 25% patients died, and 40.9% had recurrence. On multivariate analysis, elevated preoperative NLR-PLR was predictive of both OS (HR 2.496; CI 1.156-5.389; p =0.020) and RFS (HR 1.917; CI 1.161-3.166; p =0.011). The 5-year OS was 76% for NLR-PLR=0 group, 21.7% for the NLR-PLR=1 group, and 61.1% for the NLR-PLR=2 group, respectively. The 5-year RFS was 39.3% for the NLR-PLR=0 group, 18.4% for the NLR-PLR=1 group, and 21.1% for the NLR-PLR=2 group, respectively.
Conclusion
The preoperative NLR-PLR is predictive of both OS and RFS in patients with HCC undergoing curative liver resection.
Autor:innen und Institutionen
- Department of General Surgery, Tan Tock Seng Hospital, Singapore.
ORCID-Profile: T Kabir, M Ye, V G Shelat
Zitieren
APA
Kabir, T., Ye, M., Mohd Noor, N. A., Woon, W., Junnarkar, S. P., & Shelat, V. G. (2019). Preoperative Neutrophil-to-Lymphocyte Ratio Plus Platelet-to-Lymphocyte Ratio Predicts the Outcomes after Curative Resection for Hepatocellular Carcinoma. International Journal of Hepatology, 2019, 1-9. https://doi.org/10.1155/2019/4239463
Vancouver
Kabir T, Ye M, Mohd Noor NA, Woon W, Junnarkar SP, Shelat VG. Preoperative Neutrophil-to-Lymphocyte Ratio Plus Platelet-to-Lymphocyte Ratio Predicts the Outcomes after Curative Resection for Hepatocellular Carcinoma. International Journal of Hepatology. 2019;2019:1-9. doi:10.1155/2019/4239463
BibTeX
@article{Kabir2019,
author = {Kabir, T and Ye, M and Mohd Noor, N A and Woon, W and Junnarkar, S P and Shelat, V G},
title = {Preoperative Neutrophil-to-Lymphocyte Ratio Plus Platelet-to-Lymphocyte Ratio Predicts the Outcomes after Curative Resection for Hepatocellular Carcinoma},
journal = {International Journal of Hepatology},
year = {2019},
volume = {2019},
pages = {1--9},
doi = {10.1155/2019/4239463}
}
EUVIMED